International Faculty

Dr. James P. Allison

Regental Professor & Chair, Department of Immunology, Olga Keith Wiess Distinguished University Chair for Cancer Research, Director, Parker Institute for Cancer Research, Executive Director, Immunotherapy Platform, MD Anderson Cancer Center

Dr. Jedd D. Wolchok

Chief, Immuno-Oncology Service, Human Oncology and Pathogenesis Program Lloyd J. Old Chair, Clinical Investigation, Director, Parker Institute for Cancer Immunotherapy,Memorial Sloan Kettering, Associate Director, Ludwig Center for Cancer Immunotherapy, Professor of Medicine, Weill Medical College of Cornell University

Dr. Rakesh K. Jain

A. W. Cook Professor of Radiation Oncology (Tumor Biology) Director, E.L. Steele Laboratories Department of Radiation Oncology Harvard Medical School and Massachusetts General Hospital Boston,USA

Dr. Solange Peters

Head of the Medical Oncology Department, Head of the Specialized Consultation for Thoracic Tumors, Physician in charge of the Center for thoracic tumors University of Lausanne,

Dr. John B. Haanen

Head of the Division of Medical Oncology and Staff Scientist, Division of Immunology, Professor of Translational Immunotherapy of Cancer, Leiden University Medical Centre,
The Netherlands

Dr. Olivira J. Finn

Chair and Professor, Department of Immunology, University of Pittsburgh School of Medicine, Director of the Immunology Program, University of Pittsburgh Cancer Institute,

Dr. Padmanee Sharma

Professor,Department of Genitourinary Medical Oncology, Professor,Department of immune-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,

Dr. Sherene Loi,

MMBS (Hons), FRACP, PhD, FAHMS Professor, Cancer Therapeutics Head, Translational Breast Cancer Genomics and Therapeutics Lab Peter MacCallum Cancer Centre University of Melbourne,

Prof. Silvia Stacchiotti

Depart of Medical Oncology IRCCS Foundation,National Cancer Institute,

Dr. David Gottlieb

Professor of Haematology University of Sydney Program Director BMT, Head Cell Therapies, Westmead Hospital Sydney,

Prof. Laura Locati

Head and Neck Unit Depart of Medical Oncology IRCCS Foundation, National Cancer Institute, Milan, Italy

Dr. Ravindran Kanesvaran

Deputy Head & Senior Consultant, Division of Medical Oncology, National Cancer Centre,

Dr. Aung Naing

Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,

Dr. Naval G. Daver

Associate Professor, Department of Leukemia, MD Anderson Cancer Center,

Dr. Aditi Shastri

Assistant Professor of Oncology, Division of Hematologic Malignancies & Bone Marrow Transplant, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, New York,

Dr. Boro Dropulic

Chief Science Officer
Lentigen Technology, Inc.

Nirali N. Shah

M.D., M.H.Sc.
Investigator,Pediatric Oncology Branch,
NIH Lasker Clinical Research Scholar,
NIH Distinguished Scholar Head,
Hematologic Malignancies Section,
Center for Cancer Research National Cancer Institute